These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7689276)

  • 21. Compassionate use of FK 506 in liver transplantation.
    Murio JE; Balsells J; Lázaro JL; Charco R; Margarit C
    Transplant Proc; 1995 Aug; 27(4):2336. PubMed ID: 7544501
    [No Abstract]   [Full Text] [Related]  

  • 22. FK 506 rescue therapy in liver transplantation: outcome and complications.
    McDiarmid SV; Klintmalm G; Busuttil RW
    Transplant Proc; 1991 Dec; 23(6):2996-9. PubMed ID: 1721339
    [No Abstract]   [Full Text] [Related]  

  • 23. FK 506 rescue therapy in liver transplant recipients with drug-resistant rejection.
    Lewis WD; Jenkins RL; Burke PA; Winn KM; Shaffer D; Lopez R; Monaco AP
    Transplant Proc; 1991 Dec; 23(6):2989-91. PubMed ID: 1721336
    [No Abstract]   [Full Text] [Related]  

  • 24. Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine.
    Park KM; Hay JE; Lee SG; Lee YJ; Wiesner RH; Porayko MK; Krom RA
    Transplant Proc; 1996 Jun; 28(3):1738-40. PubMed ID: 8658863
    [No Abstract]   [Full Text] [Related]  

  • 25. FK 506 rescue therapy for intractable liver allograft rejection.
    Wong P; Devlin J; Gane E; Ramage J; Portmann B; Williams R
    Transpl Int; 1994; 7 Suppl 1():S70-6. PubMed ID: 11271339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategy for chronic rejection in recipient of living-related liver transplantation.
    Koyamada N; Ohkohchi N; Doi H; Orii T; Kikuchi H; Chubachi S; Sekiguchi S; Kawagishi N; Haga I; Nakajima N; Satomi S; Oguma S
    Transplant Proc; 2000 Nov; 32(7):2134-6. PubMed ID: 11120102
    [No Abstract]   [Full Text] [Related]  

  • 27. Rejection: FK 506 for rescue or maintenance.
    Klintmalm GB; Gibbs JF; McMillan R; Backman L; Levy M; Goldstein RM; Husberg BS; Holman MJ; Gonwa TA
    Transplant Proc; 1993 Apr; 25(2):1914-5. PubMed ID: 7682356
    [No Abstract]   [Full Text] [Related]  

  • 28. Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
    Bechstein WO; Neuhaus P; McMaster P; Calne R; Pichlmayr R; Otto G; Williams R; Ericzon BG; Bismuth H
    Transplant Proc; 1996 Apr; 28(2):1008-10. PubMed ID: 8623211
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506.
    Takaya S; Bronsther O; Abu-Elmagd K; Ramos H; Fung JJ; Todo S; Starzl TE
    Transplant Proc; 1993 Jun; 25(3):2381-5. PubMed ID: 7685953
    [No Abstract]   [Full Text] [Related]  

  • 30. Distinct intragraft cytokine gene expression patterns during acute hepatic rejection under cyclosporine versus FK 506 primary immunosuppression.
    Gaweco AS; Otto G; Otto HF; Geisse T; Hofmann WJ
    Transplant Proc; 1994 Dec; 26(6):3111-3. PubMed ID: 7527948
    [No Abstract]   [Full Text] [Related]  

  • 31. Outcome analysis of FK 506 therapy for acute and chronic rejection.
    Gibbs JF; Husberg BS; Klintmalm GB; Backman L; Levy M; McMillan R; Goldstein RM; Holman MJ; Gonwa TA; Morris C
    Transplant Proc; 1993 Feb; 25(1 Pt 1):622-3. PubMed ID: 7679823
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group.
    Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):635-7. PubMed ID: 7679826
    [No Abstract]   [Full Text] [Related]  

  • 33. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 34. Experience in therapy of chronic liver allograft rejection.
    Charco R; Ruiz C; Allende E; Balsells J; Lazaro JL; Murio E; Bilbao I; Gifre E; Margarit C
    Transplant Proc; 1995 Aug; 27(4):2293-4. PubMed ID: 7652811
    [No Abstract]   [Full Text] [Related]  

  • 35. Intensive care after orthotopic liver transplantation.
    Sun CK; Chen CL; Kuo YC; Chen YS
    Transplant Proc; 1994 Aug; 26(4):2246-7. PubMed ID: 7520627
    [No Abstract]   [Full Text] [Related]  

  • 36. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common and sequential overexpression patterns of T-helper cytokines during acute (cellular) rejection, and correlation of proinflammatory cytokine expression with chronic (ductopenic) rejection of human liver allografts: a study under cyclosporine, FK 506, and quadruple BT 563 immunosuppression.
    Gaweco AS; Otto G; Otto HF; Meuer S; Geisse T; Hofmann WJ
    Transplant Proc; 1995 Feb; 27(1):1152-4. PubMed ID: 7533370
    [No Abstract]   [Full Text] [Related]  

  • 38. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?
    Dé P; Bechstein WO; Blumhardt G; Lange D; Schattenfroh N; Neuhaus P
    Transplant Proc; 1993 Aug; 25(4):2693-4. PubMed ID: 7689279
    [No Abstract]   [Full Text] [Related]  

  • 40. The impact on biochemical profiles and allograft function for patients converted from cyclosporine to tacrolimus after clinical heart transplantation.
    Wang CH; Chou NK; Ko WJ; Chi NH; Tsao CI; Wang SS
    Transplant Proc; 2008 Oct; 40(8):2600-2. PubMed ID: 18929812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.